logo
New Cadent Study Finds TV Ads Rival Doctors in Driving Awareness of New Medications Across Key Demographics

New Cadent Study Finds TV Ads Rival Doctors in Driving Awareness of New Medications Across Key Demographics

Yahoo5 days ago
More than half of Americans find new medications through CTV and linear ads, according to recent data in pharmaceutical advertising
NEW YORK, July 16, 2025 /PRNewswire/ -- Cadent, the predictive advertising company, today announced findings from its new study, Cadent Pharma Advertising Trends, fielded with The Harris Poll. The findings revealed that while doctors and healthcare providers remain the primary source for respondents to learn about new medications (68%), TV and connected TV (CTV) ads are gaining traction, at 62%.
The study surveyed over 4,000 US consumers to achieve a more inclusive understanding of healthcare perceptions. With a focus on the impact of pharma advertising on multicultural groups, the survey explored trends within Hispanic, Black, White, and Asian demographics.
"Harnessing the power of CTV and cross-screen advertising is crucial for pharmaceutical advertisers," said Bradley Deutsch, SVP at Cadent Health. "Seventy-six percent of consumers are more inclined to take action after encountering an ad across multiple devices. These platforms don't just introduce new medications–they are a critical factor for driving brand awareness and engagement throughout the patient journey, encouraging consumers to discuss the advertised medications with their healthcare providers."
More findings from the report include:
CTV tops linear TV for Hispanic Americans: Hispanic Americans are more likely to discover prescription medicines from ads on CTV (33%) than ads on linear TV (28%).
Mobile ads drive action: After seeing a medication ad on mobile, 73% of Americans reported being likely to ask their doctor about a prescription medication, research an over-the-counter medication (71%), and buy over-the-counter medications (64%).
Black Americans are most comfortable with AI-generated ad campaigns: 61% of Black Americans are comfortable with targeted online ads featuring AI-generated content, followed by 57% of Hispanic Americans. Only 38% of White Americans and 37% of Asian Americans are in agreement.
QR codes capture attention: Nearly half (47%) of Americans are inclined to scan a QR code for more details after viewing a medication ad on CTV. Among them, Black Americans lead at 68%, followed by Hispanic Americans at 63%, Asian Americans at 44%, and White Americans at 40%.
"Given the evolving landscape and the potential shifts in how pharmaceutical advertisements are delivered, understanding where your audience is engaging and how to connect with them is more critical than ever," continued Bradley Deutsch, SVP at Cadent Health. "Pharmaceutical advertisers can effectively reach and engage their target audience by leveraging these insights—without compromising individual privacy. Trust and education are key drivers of engagement, particularly in healthcare, where consumers increasingly value informative, relevant content. Highlighting specific demographics empowers marketers to create culturally relevant and educational campaigns that not only resonate with diverse audiences, but also foster trust—ensuring no one is left behind in healthcare communication."
To learn more about Cadent or to download the full report, visit https://info.thenewcadent.com/cadent-pharma-advertising-trends-report.
About CadentCadent ignites seamless connections between brands, publishers and consumers. Our advanced predictive models orchestrate outcomes on any platform customers are on, across any media they consume, and at any stage of their journey. Through our transparent, enterprise-class platform that adapts in real time and connects with hundreds of partners, we drive measurable outcomes across every screen. Learn more at www.TheNewCadent.com.
About The Harris PollThe Harris Poll is one of the longest running surveys in the U.S. tracking public opinion, motivations and social sentiment since 1963 that is now part of Harris Insights & Analytics, a global consulting and market research firm that delivers social intelligence for transformational times. We work with clients in three primary areas; building twenty-first-century corporate reputation, crafting brand strategy and performance tracking, and earning organic media through public relations research. Our mission is to provide insights and advisory to help leaders make the best decisions possible. To learn more, please visit www.theharrispoll.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-cadent-study-finds-tv-ads-rival-doctors-in-driving-awareness-of-new-medications-across-key-demographics-302506856.html
SOURCE Cadent
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How I'm Learning to Outlive My Mother
How I'm Learning to Outlive My Mother

Yahoo

time12 minutes ago

  • Yahoo

How I'm Learning to Outlive My Mother

Whenever I miss my mom, I reach for my favorite photo of me and her. We're sitting on the steps in front of my childhood home in Massachusetts, cuddled up next to each other. I'm three years old and proudly wearing blue clip-on earrings to match my white puff-sleeve dress. My mother is flashing a smile that takes up so much space, it's sometimes all I can see. Happy photos like this one, which is protected in a heart-shaped frame, decorate the shelves in my home office. The sadder ones — taken after my mother was diagnosed with metastatic breast cancer — hide inside my desk drawers. They're out of sight, but the truth is, they're always on display in my mind. They sit alongside the many journals in which my mother kept track of my childhood accomplishments and made predictions about my future. 'Mallary's going to go places with her writing,' she wrote in one of them, believing I would one day become an author. 'I'm so proud of her.' My mom passed away from cancer when I was 11, before she could see me graduate middle school, let alone go off to college, pursue a writing career, get married, and have kids. She was just 40 years old when she died — the same age I am now. As I begin to outlive my mother, I've been pondering questions that lack easy answers: How do I venture into this next phase of life that she never got to experience? What are the lessons she taught me (and didn't get to teach) that I want to pass on to my own children? And how can I continue to keep my mom's memory alive? On my 40th birthday, I told my 7-year-old son and 9-year-old daughter why this particular birthday was so significant. They've heard me share stories about my mother for years, but this was the first time they learned how old she'd been when she passed away. 'Just because your mom died when you were 40 doesn't mean you're going to, right, Mommy?' my daughter asked, making my heart sink. 'Oh no honey, I'm not going to die at 40,' I reassured her. 'My mother was sick, but I'm not. I hope to be around for a loooong time.' My words were tightly woven together by years of convincing myself that I won't die young. And yet I know the unpredictability of life could unravel these words at any point, rendering them a lie in my children's minds. I hope my words remain true, but the reality of mortality seems to loom larger now that I'm 40. In some ways it's a relief to have outlived my mother, because it feels like a sign that my fate will not follow hers. But I also find myself wondering: How much longer do I really have? Grief expert Hope Edelman once told me that when you begin to outlive your deceased parent, you are 'crossing the silent threshold.' When experiencing this rite of passage, she said, it's normal to grow fearful about dying and/or to experience mourning anew. Edelman recommends honoring the silent threshold by naming it and recognizing what surfaces. If growing up meant living without my mother, then I wanted to stay in the past forever. I've been recognizing it by going through the photos in my desk drawers and exposing the hard truths behind them. There's one in particular that I keep returning to — a picture of me looking happy as can be just five days after my mother's death. I was at my first-ever middle school dance, smiling and looking perfectly poised, like a ballerina about to do a pirouette. I thought I was supposed to be 'strong' and 'resilient,' so I tried pretending to be okay. But behind that happy facade was a little girl who felt like her whole world had fallen apart. If growing up meant living without my mother, then I wanted to stay in the past forever. I remember doing the math as I got ready for the dance, counting out exactly how many hours and minutes had passed since my mother died; they say time heals, but I learned at a young age that time also hurts. Every birthday, holiday, and missed milestone became a painful reminder of the permanence of my mother's absence. When you lose a parent at a young age, you're always playing a game of catch-up that reminds you of not just who you've lost but what you've lost — all those life lessons that you hope your mom would have shared to help you navigate the world. Having lost my mother just before my teenage years, I found it especially difficult to navigate puberty without her. I wanted her to teach me everything I thought a teenage girl was supposed to learn: how to use an eyelash curler, shop for bras, insert a tampon, and shave my legs. I feel a pang whenever I look at one close-up photo of me as a 14-year-old, with eyelashes that were clumped together by far too much Maybelline mascara. I had taught myself how to apply it, hoping that it would help me look more like my mom, who had always worn it until she got too sick and weak to put it on. But it wasn't until age 38 that I learned how to properly use an eyelash curler. I had always applied my mascara and then curled my lashes, until one day a friend told me I was supposed to do it the other way around. How did I not know that? I thought to myself, feeling the load of loss grow heavier. Soon enough, when my lip-gloss-loving daughter expresses interest in makeup, I will show her how the curler works. Until then, I'm trying to teach my kids the bigger life lessons that my mom shared with me when I was young: how to persevere in the face of uncertainty, work hard for what you want, and show familial love. Lately I've felt a greater sense of urgency around sharing these lessons, especially when I think about what else is hiding in my desk drawers: genetic test results showing that, as my mother's daughter, I'm at a higher risk of developing breast cancer compared to other women my age. As I enter midlife, it saddens me to know that my mom never got to witness all the places I've gone with my writing — and that she won't get to celebrate alongside me when my debut memoir is published this summer. But I find comfort in knowing that she was there from the very start, believing in me and giving me reason to feel hopeful about the future. Mallary Tenore Tarpley is a journalism professor at the University of Texas at Austin and author of the memoir SLIP. The post How I'm Learning to Outlive My Mother appeared first on Katie Couric Media. Solve the daily Crossword

Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings

Yahoo

time12 minutes ago

  • Yahoo

Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings

We recently published Elevance Health, Inc. (NYSE:ELV) is one of this week's top performers. Elevance Health fell by 18.66 percent week-on-week to close at $277.09 on Friday versus $340.67 a week earlier following dismal earnings performance in the second quarter of the year. In its earnings release, Elevance Health, Inc. (NYSE:ELV) said net income during the period dropped by 24.2 percent to $1.744 billion from $2.301 billion in the same period last year, pushing its six-month net earnings lower by 13.7 percent to $3.928 billion from $4.55 billion year-on-year. Revenues for the second quarter, however, increased by 13.4 percent to $49.776 billion from $43.886 billion year-on-year, while revenues for the first half of the year grew by 14.1 percent to $98.667 billion from $86.463 billion year-on-year. A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers. Looking ahead, Elevance Health, Inc. (NYSE:ELV) also lowered its guidance amid elevated medical cost trends in Obamacare and slower rate alignment in Medicaid. Given the industry-wide impact of elevated cost trends, the company said it now expects 2025 GAAP net income per diluted share to be approximately $24.10 and adjusted net income per diluted share to be approximately $30. While we acknowledge the potential of ELV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio

Centene (CNC) Falls 11.1% on Investor Caution Ahead of Q2
Centene (CNC) Falls 11.1% on Investor Caution Ahead of Q2

Yahoo

time12 minutes ago

  • Yahoo

Centene (CNC) Falls 11.1% on Investor Caution Ahead of Q2

We recently published Centene Corporation (NYSE:CNC) is one of this week's top performers. Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further dampened by one of its peers' dismal earnings performance. During the week, its fellow insurer Elevance Health, reported a 24.2-percent drop in net income during the second quarter of the year and updated its outlook to reflect elevated medical cost trends under the Affordable Care Act and slower rate alignment in Medicaid, both of which are also being offered by Centene Corporation (NYSE:CNC). Last month, Centene Corporation (NYSE:CNC) withdrew its 2025 earnings forecast due to an expected slump in its revenues from commercial plans under the ACA or Obamacare. The withdrawal triggered a review from credit ratings issuer S&P Global Ratings, saying that it is likely to set the company's status to 'junk.' A doctor holding a clipboard in a hospital ward, discussing patient treatment plan with the nurses. 'With the removal of earnings guidance, we have less immediate clarity and confidence on the company's capital adequacy trajectory, as well as the overall strength of its business and execution capabilities,' S&P said. While we acknowledge the potential of CNC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store